Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
SEC Accession No. 0001140361-22-023370
Filing Date
2022-06-17
Accepted
2022-06-17 08:03:22
Documents
1
Group Members
INNOVIVA MERGER SUB, INC.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13E-3/A ny20004467x2_sc13e3a.htm SC 13E3/A 21406
  Complete submission text file 0001140361-22-023370.txt   23301
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filed by) CIK: 0001080014 (see all company filings)

EIN.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13E3/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Subject) CIK: 0001724344 (see all company filings)

EIN.: 824592913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13E3/A | Act: 34 | File No.: 005-90651 | Film No.: 221022419
SIC: 2834 Pharmaceutical Preparations